{"version":"1.0","type":"link","title":"Real-world description of patients with resected epidermal growth factor receptor mutation positive non-small cell lung carcinoma treated with adjuvant osimertinib in an early access program in Italy: the ELBA observational study.","author_name":"Pasello G 외","author_url":"https://prs-insight.online/author/Pasello%20G","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/97112","thumbnail_width":1200,"thumbnail_height":630}